New Product Launch Pharmaceutical Strategies Group (Psg) Announces Artemetrx Extend
Artemetrx, the industry’s most preeminent platform for integrated drug cost management, is now even more robust with the launch of its new module, Artemetrx Extend. With greater insights and analytics, Artemetrx Extend is a custom reporting tool that provides unparalleled data access through its user-friendly platform.
“Artemetrx delivers swift and easy access to valuable drug management insights. With Artemetrx Extend, our clients will be able to further tap into the rich integrated dataset of the Artemetrx platform,” said Libby Johnson, PSG Chief Data and Analytics Officer. “Artemetrx Extend continues our long legacy of client advocacy and innovation, as the industry’s best keeps getting better.”
AI News: An Investment Into Artificial Intelligence as Daktela Buys Coworkers.ai
Can your organization quickly get its data-driven questions answered? Most plans get bogged down waiting for custom analytics when Artemetrx can respond in seconds. The major capabilities now available within Artemetrx Extend, through powerful filtering and drill downs, include the ability to:
- Determine how many members have medical claims associated with a diagnosis for a specific group
- Analyze the specific diagnoses that a particular drug is prescribed to treat for a population based on claims history
- Model the financial impact of switching from one preferred medication to another
- View spend and trend statistics on all drugs (specialty/non-specialty, medical/pharmacy) or search based on National Drug Code, Healthcare Common Procedure Coding System, or drug name
- Latest Aithority Insights : Got It AI Announces AutoFlows, a Breakthrough Autonomous Conversational AI
There are two versions of Artemetrx Extend available: Base Access is available for all users, and Power User Access is optional, allowing for custom report and dashboard building and the ability to save and share reports.
Artemetrx is a proprietary industry-leading web-based software for integrated drug management developed by Pharmaceutical Strategies Group. Artemetrx Extend is the latest in a series of innovations on the Artemetrx platform.
AiThority Interview : AiThority Interview with Hardy Myers, SVP of Business Development & Strategy at Cognigy
[To share your insights with us, please write to sghosh@martechseries.com]
Comments are closed.